Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma.
Masami YamauchiAtsushi OnoKei AmiokaYasutoshi FujiiHikaru NakaharaYuji TeraokaShinsuke UchikawaHatsue FujinoTakashi NakaharaEisuke MurakamiWataru OkamotoDaiki MikiTomokazu KawaokaMasataka TsugeMichio ImamuraC Nelson HayesWaka OhishiTakeshi KishiMizuki KimuraNatsumi SuzukiKoji ArihiroHiroshi AikataKazuaki ChayamaShiro OkaPublished in: Communications medicine (2023)
Our findings show the ability of lenvatinib to modulate tumor immunity in clinical samples of hepatocellular carcinoma.
Keyphrases